A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152

NCT02502721 ·Status: COMPLETED ·Phase: PHASE1

The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects

NCT04686825 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

NCT05812404 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

NCT05017987 ·Status: COMPLETED ·Phase: PHASE1

Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects

NCT02171572 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects

NCT00856570 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects

NCT02207595 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers

NCT05737082 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions

NCT06357910 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

NCT04654078 ·Status: COMPLETED ·Phase: PHASE1

A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects

NCT02020486 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

NCT06916169 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Phase 1 Study of the Pharmacokinetics of RDC5 in Healthy Volunteers

NCT02016742 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322

NCT07312799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

NCT04961905 ·Status: COMPLETED ·Phase: PHASE1

A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

NCT05198778 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2

NCT03802526 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults

NCT03646799 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetic Study for PCA Derivate Formulations

NCT00729729 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

NCT02170571 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment

NCT05856513 ·Status: COMPLETED ·Phase: PHASE1

Study of NST-6179 in Healthy Subjects

NCT05181085 ·Status: COMPLETED ·Phase: PHASE1

A Study of TMC207 in Patients With Moderately Impaired Hepatic Function

NCT01012284 ·Status: COMPLETED ·Phase: PHASE1

A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement

NCT06985615 ·Status: RECRUITING ·Phase: PHASE1

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults

NCT03849261 ·Status: UNKNOWN ·Phase: PHASE1